Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 5, 2009, Pages

  Yew, Wing Wai ^a   Chang, Kwok Chiu ^b   Chau, Chi Hung ^a  

^a GRANTHAM HOSPITAL   (Hong Kong)

^b DEPARTMENT OF HEALTH   (China)

Author keywords

Dosage; Oxazolidinones; TB

Indexed keywords

LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; OXAZOLIDINONE DERIVATIVE; PNU 100480; UNCLASSIFIED DRUG; ACETAMIDE DERIVATIVE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; DOSE RESPONSE; DRUG BLOOD LEVEL; HUMAN; LETTER; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; TUBERCULOSIS; ANTIBACTERIAL ACTIVITY; DRUG RESPONSE; LOW DRUG DOSE; MINIMUM INHIBITORY CONCENTRATION; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; NOTE; ARTICLE;

ACETAMIDES; ANTITUBERCULAR AGENTS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; OXAZOLIDINONES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 73949155995     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp291     Document Type: Letter

References (6)

1. Koh WJ, Kwon OJ, Gwak H et al. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. J Antimicrob Chemother 2009; 64: 388-91.
2. Kim DH, Kim HJ, Park SK et al. Treatment outcomes and long-erm survival in patients with extensively drug-resistant tuberculosis. Am J Respir Crit Care Med 2008; 178: 1075-82.
3. Conte JE Jr, Golden JA, Kipps J et al. Intrapulmonary pharmaco-inetics of linezolid. Antimicrob Agents Chemother 2002; 46: 475-80.
4. Richter E, Rüsch-Gerdes S, Hillemann D. First linezolid-resistant linical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2007; 51: 1534-6.
5. Huang TS, Liu YC, Sy CL et al. In vitro activities of linezolid gainst clinical isolates of Mycobacterium tuberculosis complex iso-ated in Taiwan over 10 years. Antimicrob Agents Chemother 2008; 52: 226-7.
6. Yew WW, Chau CH, Wen KH. Linezolid in the treatment of "difficult" multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2008; 12: 345 6.